iShares Genomics Immunology and Healthcare ETF Rating $23.11 0.00 (0.00%) Closing price 02/21/2025 04:10 PM EasternExtended Trading$23.02 -0.09 (-0.37%) As of 02/21/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatings iShares Genomics Immunology and Healthcare ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IDNA Aggregate RatingModerate Buy 2.78Holdings in IDNA have an aggregate rating of Moderate Buy based on 399 analyst ratings issued in the past year covering 38 companies (65.0% of the portfolio).IDNA Aggregate Price Target$23.11High Prediction$23.11Average Prediction$23.11Low Prediction$23.11Holdings in IDNA have an aggregate price target of $23.11 and a range of $23.11 to $23.11 covering 38 companies (65.0% of the portfolio).IDNA Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy16 Buy rating(s)Moderate Buy16 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce2 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Genomics Immunology and Healthcare ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 38 IDNA Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.81%SWTXSpringWorks Therapeutics$58.29-2.7%1.2401 of 5 stars3.00$71.50 22.7%6Earnings ReportAnalyst ForecastInsider TradeAnalyst RevisionNews Coverage4.12%BNTXBioNTech$120.01+1.8%2.4325 of 5 stars2.88$142.72 18.9%17Positive NewsHigh Trading Volume4.10%EXELExelixis$36.85+5.0%4.6318 of 5 stars2.55$37.24 1.0%20Analyst UpgradeInsider TradeGap Up4.07%INCYIncyte$72.05+0.9%4.541 of 5 stars2.35$75.59 4.9%203.91%RVMDRevolution Medicines$41.34-2.2%4.5213 of 5 stars3.08$66.25 60.3%123.82%REGNRegeneron Pharmaceuticals$700.33+0.6%4.7649 of 5 stars2.76$973.13 39.0%25Dividend Announcement3.80%TWSTTwist Bioscience$41.31-8.4%4.6084 of 5 stars2.70$53.80 30.2%10Positive News3.72%MRKMerck & Co., Inc.$89.40+2.0%5 of 5 stars2.58$116.39 30.2%24Analyst DowngradeOptions Volume3.35%ACLXArcellx$63.75-2.8%2.0095 of 5 stars3.13$105.93 66.2%15Upcoming Earnings3.08%MRNAModerna$35.53+5.3%4.7378 of 5 stars2.04$60.63 70.6%23Analyst DowngradeOptions Volume2.53%JANXJanux Therapeutics$36.01-3.1%3.1354 of 5 stars3.08$89.90 149.7%132.47%BCRXBioCryst Pharmaceuticals$9.21-1.9%3.924 of 5 stars2.83$15.50 68.3%62.34%GERNGeron$2.58-2.1%3.0156 of 5 stars3.08$6.91 168.3%12Analyst ForecastAnalyst RevisionNews Coverage1.96%IOVAIovance Biotherapeutics$5.78+3.0%4.0357 of 5 stars2.86$21.07 264.6%71.78%NVAXNovavax$7.99+0.9%3.9838 of 5 stars2.33$17.83 123.2%6Analyst RevisionNews CoverageHigh Trading Volume1.59%XNCRXencor$15.74-0.3%3.4776 of 5 stars3.13$34.88 121.6%81.18%VIRVir Biotechnology$9.57-2.3%3.3207 of 5 stars2.83$34.83 264.0%6Insider Trade1.02%ABCLAbCellera Biologics$3.03-3.5%2.6857 of 5 stars2.67$8.00 164.0%3Upcoming Earnings0.86%RCUSArcus Biosciences$11.06+3.0%2.6121 of 5 stars2.90$29.50 166.7%10Analyst ForecastAnalyst RevisionNews Coverage0.81%KURAKura Oncology$8.25+1.2%4.3952 of 5 stars2.83$27.13 228.9%12Positive News0.79%IMNMImmunome$9.53-5.7%2.9735 of 5 stars3.00$28.60 200.1%5Positive News0.77%IBRXImmunityBio$3.42-6.0%2.0758 of 5 stars3.00$13.58 297.2%4News Coverage0.75%VERVVerve Therapeutics$7.28-7.0%2.9199 of 5 stars3.00$25.75 253.7%5Upcoming EarningsAnalyst ForecastGap Up0.67%DNAGinkgo Bioworks$10.86-5.0%0.8526 of 5 stars1.60$4.58 -57.9%5Upcoming EarningsNews CoverageGap Up0.59%MREOMereo BioPharma Group$2.86-0.5%2.8725 of 5 stars3.43$7.83 174.4%7News Coverage0.59%ORICORIC Pharmaceuticals$7.68+2.8%4.5474 of 5 stars3.00$18.71 143.7%9Earnings ReportAnalyst ForecastAnalyst RevisionGap Up0.58%ARCTArcturus Therapeutics$17.77+5.0%2.7914 of 5 stars3.14$65.00 265.8%70.57%CELCCelcuity$13.15+0.2%1.7645 of 5 stars3.14$30.17 129.4%70.53%RIGLRigel Pharmaceuticals$20.09-3.6%3.4804 of 5 stars2.40$36.20 80.2%50.52%OABIOmniAb$3.65-5.9%2.094 of 5 stars3.00$9.00 146.6%4News Coverage0.49%PACBPacific Biosciences of California$1.54-6.1%2.3208 of 5 stars2.54$2.79 81.3%13Analyst ForecastOptions VolumeAnalyst RevisionNews CoverageGap Down0.35%CRSPCRISPR Therapeutics$47.91-5.0%3.1611 of 5 stars2.50$74.40 55.3%22Analyst ForecastInsider TradeOptions VolumeAnalyst Revision0.34%SGMOSangamo Therapeutics$1.07-4.5%1.8725 of 5 stars2.67$5.17 382.9%60.30%ALLOAllogene Therapeutics$2.17-4.0%2.8268 of 5 stars2.90$9.73 348.5%10Gap Up0.26%FDMT4D Molecular Therapeutics$4.64-0.6%3.1325 of 5 stars2.60$32.13 592.3%10Analyst Forecast0.20%LGNDLigand Pharmaceuticals$120.56-1.2%4.1424 of 5 stars3.00$147.00 21.9%6Positive News0.20%BEAMBeam Therapeutics$30.43-8.2%3.1351 of 5 stars3.00$47.67 56.6%12Gap Up0.17%CRGXCARGO Therapeutics$3.77+2.2%3.094 of 5 stars1.86$15.00 297.9%7Gap Up This page (NYSEARCA:IDNA) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredBITCOINDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....Awesomely, LLC | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredEx-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000”Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000. ...Colonial Metals | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Genomics Immunology and Healthcare ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Genomics Immunology and Healthcare ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IDNA Stock Alerts